PNC Financial Services Group
MIST icon

PNC Financial Services Group’s Milestone Pharmaceuticals MIST Stock Holding History

PNC Financial Services Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Buy
+1,000
New +$1.75K ﹤0.01% 4714
2023
Q1 		– Sell
-137
Closed -$543 – 4771
2022
Q4 		$543 Hold
137
– – ﹤0.01% 4517
2022
Q3 		$1K Buy
+137
New +$1.04K ﹤0.01% 4334

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

PNC Financial Services Group's MIST Position: Q1 2026 in Review

PNC Financial Services Group opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 1,000 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #4714 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in MIST as recently as Q4 2022.

PNC Financial Services Group first reported a position in MIST in Q3 2022 and has held it in 3 quarters since. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • PNC Financial Services Group held 1,000 shares of Milestone Pharmaceuticals worth $1.19K as of Q1 2026.
  • Milestone Pharmaceuticals was a new PNC Financial Services Group position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4714 holding.
  • PNC Financial Services Group first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.